Indivior PLC
General ticker "INDV" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.0B (TTM average)
Indivior PLC follows the US Stock Market performance with the rate: 51.1%.
Estimated limits based on current volatility of 1.8%: low 35.49$, high 36.80$
Factors to consider:
- Total employees count: 1164 as of 2023
- Current price 126.0% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.94$, 15.84$]
- 2025-12-31 to 2026-12-31 estimated range: [7.80$, 15.35$]
Short-term INDV quotes
Long-term INDV plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $1,188.00MM |
| Operating Expenses | $1,156.00MM |
| Operating Income | $32.00MM |
| Non-Operating Income | $-18.00MM |
| Interest Expense | $41.00MM |
| R&D Expense | $107.00MM |
| Income(Loss) | $14.00MM |
| Taxes | $11.00MM |
| Profit(Loss)* | $2.00MM |
| Stockholders Equity | $-348.00MM |
| Inventory | $178.00MM |
| Assets | $1,319.00MM |
| Operating Cash Flow | $36.00MM |
| Capital expenditure | $29.00MM |
| Investing Cash Flow | $69.00MM |
| Financing Cash Flow | $-102.00MM |
| Earnings Per Share** | $0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.